We are a clinical coordinating center working to expand scientific knowledge and improve public health through clinical trials and epidemiologic research.
This #NationalVolunteerWeek, we want to highlight our 2026 Federal Advocate of the Year, Dr. Henry Rodriguez!
Learn more about his outstanding commitment, leadership, and tireless advocacy on behalf of people living with diabetes across the US: https://t.co/DcFSB4gSgv
The latest study from PEDIG on full-time alternate day patching in treating intermittent exotropia in children came out earlier this month! https://t.co/GYQngi8vCx
A recent review published in JAMA authored by GCDTR’s @JacobsenLM and Desmond A. Schatz highlights key advances in understanding autoimmune mechanisms, early detection, and evolving treatment strategies.
https://t.co/lJxS36s3T5
Primary results from the CALEC study were published in March of last year and still generating plenty of interest, check out this write up in Nat Geo!
https://t.co/7bQqm2aign
Interesting debate at #ATTD2026 : Is it time for continuous glucose monitoring metrics to replace hemoglobin A1c in #diabetes management? https://t.co/njJiKCIu7z
Results from the INHALE-1 study focusing on treatment of post-meal hyperglycemia came out last week in Diabetes Technology & Therapeutics!
https://t.co/srroJ70BXv
Our founder and senior medical director Dr. Roy Beck sat down with Endocrine Today to discuss the implications of the T2IQP study! https://t.co/p3Szy82s70
Diabetes is the nation's most expensive chronic disease, costing our economy nearly $413 billion annually. At Call to Congress and every day, we call for robust federal resources for prevention, treatment, and research to end the diabetes epidemic. #ADACall2Congress
🚀Hello from #ATTD2026!
Four days of innovation in diabetes tech and care begin today. Sessions start at 09:00, including ATTD Ignite. Join us tonight for the Opening Session & Welcome Reception.
🔗https://t.co/ukfgQIinpb
#DiabetesTech#DiabetesInnovation
💡 Dr. Roy Beck of @JaebCenter shares why children with #diabetes using technosphere #insulin had an increase in HbA1c over 1 year.
Read our full coverage of the INHALE-1 extension study ⬇️
@MannKindCorp@IDinChildren
https://t.co/D2CmIaKRBZ
Attending ATTD in Barcelona this week? Be sure to check out the latest presentations from JCHR. Our teams are sharing impactful work focused on advancing innovation, improving outcomes, and shaping the future of diabetes care.
“A1C can lie. Time in range does not.” — Sugar Queens’ @JenniferGoldman explains why CGM is standard of care in T1D, and why evidence-based pregnancy care increasingly depends on it for insulin use in T2D.
WATCH HERE: https://t.co/fhUUi0vtbX
Attending ATTD in Barcelona next week? Don’t miss the Leona M. and Harry B. Helmsley Charitable Trust Symposium focused on exercise and type 1 diabetes. If exercise and T1D are part of your work, or your passion, this is one you’ll want on your schedule. We hope to see you there!
Attending ATTD in Barcelona next week? Be sure to check out the latest presentations from JCHR! Our teams are sharing impactful work focused on advancing innovation, improving outcomes, and shaping the future of diabetes care.
🗣️ Hear more from Dr. Roy Beck of @JaebCenter as he discusses his recently published study analyzing HbA1c change around subgroups of adults with type 2 #diabetes in the 2IQP trial.
Read the full story 👇
@GoHealio
https://t.co/3RrxqcfZj3